GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Cyclically Adjusted Price-to-FCF

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Cyclically Adjusted Price-to-FCF : 45.30 (As of Jun. 03, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-03), Anhui Anke Biotechnology (Group) Co's current share price is ¥9.06. Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥0.20. Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF for today is 45.30.

The historical rank and industry rank for Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300009' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 40.05   Med: 175   Max: 440.42
Current: 44.97

During the past years, Anhui Anke Biotechnology (Group) Co's highest Cyclically Adjusted Price-to-FCF was 440.42. The lowest was 40.05. And the median was 175.00.

SZSE:300009's Cyclically Adjusted Price-to-FCF is ranked better than
52.43% of 103 companies
in the Biotechnology industry
Industry Median: 48.91 vs SZSE:300009: 44.97

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Anhui Anke Biotechnology (Group) Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ¥0.100. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.20 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Price-to-FCF Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.11 136.55 83.70 65.77 46.13

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.79 51.51 55.76 46.13 43.05

Competitive Comparison of Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=9.06/0.20
=45.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Anhui Anke Biotechnology (Group) Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.1/115.1156*115.1156
=0.100

Current CPI (Mar. 2025) = 115.1156.

Anhui Anke Biotechnology (Group) Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.029 99.500 0.034
201509 0.015 100.500 0.017
201512 0.020 100.600 0.023
201603 -0.012 102.200 -0.014
201606 0.043 101.400 0.049
201609 0.022 102.400 0.025
201612 0.068 102.600 0.076
201703 -0.003 103.200 -0.003
201706 0.012 103.100 0.013
201709 0.038 104.100 0.042
201712 0.055 104.500 0.061
201803 0.009 105.300 0.010
201806 0.031 104.900 0.034
201809 -0.023 106.600 -0.025
201812 0.030 106.500 0.032
201903 -0.029 107.700 -0.031
201906 0.005 107.700 0.005
201909 0.022 109.800 0.023
201912 0.061 111.200 0.063
202003 0.005 112.300 0.005
202006 0.043 110.400 0.045
202009 0.031 111.700 0.032
202012 0.128 111.500 0.132
202103 0.042 112.662 0.043
202106 0.044 111.769 0.045
202109 0.102 112.215 0.105
202112 0.107 113.108 0.109
202203 0.050 114.335 0.050
202206 0.027 114.558 0.027
202209 0.066 115.339 0.066
202212 -0.007 115.116 -0.007
202303 0.086 115.116 0.086
202306 0.071 114.558 0.071
202309 0.129 115.339 0.129
202312 0.170 114.781 0.170
202403 0.060 115.227 0.060
202406 0.021 114.781 0.021
202409 0.108 115.785 0.107
202412 0.147 114.893 0.147
202503 0.100 115.116 0.100

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Anhui Anke Biotechnology (Group) Co  (SZSE:300009) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Anke Biotechnology (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhao Hui Directors, executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines